- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01906099
Effects of Legume Intake on Cardiovascular Risk Factors Among Adults at Risk for Diabetes
July 18, 2013 updated by: Leila Azadbakht, Isfahan University of Medical Sciences
This randomized cross-over study was designed to investigate the effects of legume enriched diet consumption on cardiovascular risk factors among first degree relatives of diabetic patients.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
26
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Isfahan, Iran, Islamic Republic of
- Isfahan University of Medical Sciences
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
30 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- subjects aged more than 30 years
- no history of chronic diseases
- no use of blood glucose lowering drugs be wiling to participate to study
Exclusion Criteria:
- do not follow study protocol
- incidence of chronic diseases during the study
- to start use of blood glucose lowering drugs or to change dose and type of current medications
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: healthy dietary recommendations
no nutritional intervention
|
|
Experimental: legume enriched diet
legume consumption, 4 servings per week, for 6 weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Fasting blood glucose (mg/dl)
Time Frame: 14 weeks
|
amounts of FBG
|
14 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Hemoglobin A1C (%)
Time Frame: 14 weeks
|
amounts of HbA1C
|
14 weeks
|
Total cholesterol (mg/dl)
Time Frame: 14 weeks
|
amounts of TC
|
14 weeks
|
Low Density Lipoprotein (mg/dl)
Time Frame: 14 weeks
|
amounts of LDL
|
14 weeks
|
High Density Lipoprotein (mg/dl)
Time Frame: 14 weeks
|
amounts of HDL
|
14 weeks
|
Triglyceride (mg/dl)
Time Frame: 14 weeks
|
amounts of TG
|
14 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2012
Primary Completion (Actual)
January 1, 2013
Study Completion (Actual)
March 1, 2013
Study Registration Dates
First Submitted
July 9, 2013
First Submitted That Met QC Criteria
July 18, 2013
First Posted (Estimate)
July 23, 2013
Study Record Updates
Last Update Posted (Estimate)
July 23, 2013
Last Update Submitted That Met QC Criteria
July 18, 2013
Last Verified
July 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- legume intake and CVD risks
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus, Type 2
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Mannkind CorporationTerminatedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
-
Scripps Whittier Diabetes InstituteSan Diego State UniversityCompletedType 2 Diabetes Mellitus (T2DM)United States
-
RWTH Aachen UniversityBoehringer IngelheimCompletedDiabetes Mellitus Type 2 (T2DM)Germany
-
US Department of Veterans AffairsAmerican Diabetes AssociationCompletedType 2 Diabetes MellitusUnited States
-
Dexa Medica GroupCompletedType-2 Diabetes MellitusIndonesia
-
Griffin HospitalCalifornia Walnut CommissionCompletedDIABETES MELLITUS TYPE 2United States
-
University Hospital Inselspital, BerneCompletedType 2 Diabetes MellitusSwitzerland
-
India Diabetes Research Foundation & Dr. A. Ramachandran...CompletedTYpe 2 Diabetes MellitusIndia
-
AstraZenecaRecruiting
Clinical Trials on nutritional intervention
-
Clinica Universidad de Navarra, Universidad de...Recruiting
-
China-Japan Friendship HospitalRecruiting
-
HAN University of Applied SciencesFrieslandCampina; HAS Hogeschool; Centre of Expertise Food (CoE Food); SligroCompletedMalnutrition; Protein | Protein MalnutritionNetherlands
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)CompletedObesity | OverweightUnited States
-
Gødstrup HospitalDanish Cancer SocietyNot yet recruitingCancer | Malnutrition | Nutritional InterventionDenmark
-
CHU de Quebec-Universite LavalCanadian Institutes of Health Research (CIHR); Laval UniversityRecruitingPregnancy Complications | Gestational DiabetesCanada
-
Johannes Gutenberg University MainzGoethe UniversityCompletedDiabetes Mellitus, Type 2 | Hyperlipidemias | NASH - Nonalcoholic SteatohepatitisGermany
-
Hospices Civils de LyonCompleted
-
University of ZurichCompletedHealthy ControlsSwitzerland